European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis

Journal of Clinical Microbiology

Volumn 46, Issue 8, 2008, Pages 2605-2612

  Cagnacci, Simone ^a   Gualco, Laura ^a   Debbia, Eugenio ^a   Schito, Gian Carlo ^a   Marchese, Anna ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; MECILLINAM; NALIDIXIC ACID; NITROFURANTOIN; OUTER MEMBRANE PROTEIN F; PROTEIN PARC; TETRACYCLINE; ANTIINFECTIVE AGENT; BETA LACTAMASE; ESCHERICHIA COLI PROTEIN; QNR PROTEIN, E COLI;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; CLONAL VARIATION; CONTROLLED STUDY; CYSTITIS; ESCHERICHIA COLI; EUROPE; HUMAN; ITALY; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; POLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSED FIELD GEL ELECTROPHORESIS; QNRB GENE; RANDOM AMPLIFIED POLYMORPHIC DNA; SEROTYPE; SOUTHERN EUROPE; SPAIN; URINARY TRACT INFECTION; ADULT; BACTERIUM IDENTIFICATION; CLASSIFICATION; CLUSTER ANALYSIS; COMMUNICABLE DISEASE; DNA FINGERPRINTING; DNA SEQUENCE; DRUG EFFECT; ENTEROBACTER INFECTION; EPIDEMIOLOGY; FEMALE; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; SEROTYPING;

ESCHERICHIA COLI;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CIPROFLOXACIN; CLUSTER ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; CYSTITIS; DNA FINGERPRINTING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; EUROPE; FEMALE; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHYLOGENY; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SEQUENCE ANALYSIS, DNA; SEROTYPING;

EID: 53149149100     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00640-08     Document Type: Article

References (41)

1. Aschbacher, R., M. Doumith, D. M. Livermore, C. Larcher, and N. Woodford. 2008. Linkage of acquired quinolone resistance (qnrS1) and metallo-beta-lactamase (blaVIM-1) genes in multiple species of Enterobacteriaceae from Bolzano, Italy. J. Antimicrob. Chemother. 61:515-523.
2. Bonnet, R. 2004. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14.
3. Cagnacci, S., L. Gualco, S. Roveta, S. Mannelli, L. Borgianni, J. D. Docquier, F. Dodi, M. Centanaro, E. Debbia, A. Marchese, and G. M. Rossolini. 2008. Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak. J. Antimicrob. Chemother. 61:296-300.
4. Cattoir, V., L. Poirel, V. Rotimi, C. J. Soussy, and P. Nordmann. 2007. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J. Antimicrob Chemother. 60:394-397.
5. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 63:4555-4558.
6. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M7-A7. CLSI, Wayne, PA.
7. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial disk susceptibility tests, 9th ed. Approved Standard M2-A9. CLSI, Wayne, PA.
8. Colodner, R., W. Rock, B. Chazan, N. Keller, N. Guy, W. Sakran, and R. Raz. 2004. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur. J. Clin. Microbiol. Infect. Dis. 23:163-167.
9. Dalmau, D., F. Navarro, B. Mirelis, J. Blanco, J. Garau, and G. Prats. 1996. Escherichia coli bacteraemia. Serotype O15:K52:H1 as a urinary pathogen. J. Hosp. Infect. 34:233-234.
10. Fadda, G., G. Nicoletti, G. C. Schito, and G. Tempera. 2005. Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: possible impact on guidelines. J. Chemother. 17:251-257.
11. Gobernado, M., L. Valdés, J. I. Alós, C. Garcia-Rey, R. Dal-Ré, J. García-de-Lomas, and Spanish Surveillance Group for E. coli Urinary Pathogens. 2007. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences. Rev. Esp. Quimioter. 20:206-210.
12. Ho, P. L., R. C. Wong, K. S. Yip, S. L. Loke, M. S. Leung, G. C. Mak, F. K. Chow, K. W. Tsang, and T. L. Que on behalf of the COMBAT Study Group. 2007. Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes. Diagn. Microbiol. Infect. Dis. 59:439-445.
13. Hooton, T. M., R. Besser, B. Foxman, T. R. Fritsche, and L. E. Nicolle. 2004. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin. Infect. Dis. 39:75-80.
14. Johnson, J. R., A. L. Stell, T. T. O'Bryan, M. Kuskowski, B. Nowicki, C. Johnson, J. N. Maslow, A. Kaul, J. Kavle, and G. Prats. 2002. Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe. J. Clin. Microbiol. 40:1913-1923.
15. Johnson, J. R., M. A. Kuskowski, M. Menard, A. Gajewski, M. Xercavins, and J. Garau. 2006. Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status. J. Infect. Dis. 194:71-78.
16. Johnson, J. R., K. Owens, M. Sabate, and G. Prats. 2004. Rapid and specific detection of the O15:K52:H1 clonal group of Escherichia coli by genespecific PCR. J. Clin. Microbiol. 42:3841-3843.
17. Johnson, J. R., M. A. Kuskowski, T. T. O'Bryan, R. Colodner, and R. Raz. 2005. Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob. Agents Chemother. 49:26-31.
18. Kahlmeter, G. 2003. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J. Antimicrob. Chemother. 51:69-76.
19. Karlowsky, J. A., D. J. Hoban, M. R. DeCorby, N. M. Laing, and G. G. Zhanel. 2006. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study. Antimicrob. Agents Chemother. 50:2251-2254.
20. Killigore, K. M., K. L. March, and B. J. Guglielmo. 2004. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann. Pharmacother. 38:1148-1152.
21. Lavilla, S., J. J. González-López, M. Sabaté, A. Garc?́a-Fernández, M. N. Larrosa, R. M. Bartolomé, A. Carattoli, and G. Prats. 2008. Prevalence of qnr genes among extended-spectrum beta-lactamase-producing enterobacterial isolates in Barcelona, Spain. J. Antimicrob. Chemother. 61:291-295.
22. Manges, A. R., J. R. Johnson, B. Foxman, T. T. O'Bryan, K. E. Fullerton, and L. W. Riley. 2001. Widespread distribution of urinary tract infections caused by multidrug-resistant Escherichia coli clonal group. N. Engl. J. Med. 345: 1007-1013.
23. Maslow, J. N., A. M. Slutsky, and R. D. Arbeit. 1993. Application of pulsed-field gel electrophoresis to molecular epidemiology, p. 563-572. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, DC.
24. McGee, L., L. McDougal, J. Zhou, B. G. Spratt, F. C. Tenover, R. George, R. Hakenbeck, W. Hryniewicz, J. C. Lefévre, A. Tomasz, and K. P. Klugman. 2001. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J. Clin. Microbiol. 39:2565-2571.
25. Mugnaioli, C., F. Luzzaro, F. De Luca, G. Brigante, M. Perilli, G. Amicosante, S. Stefani, A. Toniolo, and G. M. Rossolini. 2006. CTX-M-type extended-spectrum β-lactamases in Italy: molecular epidemiology of an emerging countrywide problem. Antimicrob. Agents Chemother. 50:2700-2706.
26. Naber, K. G., G. C. Schito, H. Botto, J. Palou, and T. Mazzei. Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy. Eur. Urol., in press.
27. Naber, K. G., M. C. Bishop, T. E. Bjerklund-Johansen, H. Botto, M. Çek, M. Grabe, B. Lobel, J. Palou, and P. Tenke. 2006. EAU guidelines for the management of urinary and male genital tract infections. European Association of Urology, Arnhem, The Netherlands. http://www.uroweb.org. Accessed 1 March 2008.
28. Nicolas-Chanoine, M. H., J. Blanco, V. Leflon-Guibout, R. Demarty, M. P. Alonso, M. M. Caniça, Y. J. Park, J. P. Lavigne, J. Pitout, and J. R. Johnson. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
29. Olesen, B., H. J. Kolmos, F. Orskov, and I. A. Orskov. 1995. Comparative study of nosocomial and community-acquired strains of Escherichia coli causing bacteraemia in a Danish University Hospital. J. Hosp. Infect. 31: 295-304.
30. Oliveira, D. C., A. Tomasz, and H. de Lencastre. 2002. Secrets of success of a human pathogen: molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus. Lancet Infect. Dis. 2:180-189.
31. Phillips, I., S. Eykyn, A. King, W. R. Gransden, B. Rowe, J. A. Frost, and R. J. Gross. 1988. Epidemic multiresistant Escherichia coli infection in West Lambeth Health District. Lancet 1:1038-1041.
32. Prats, G., F. Navarro, B. Mirelis, D. Dalmau, N. Margall, P. Coll, A. Stell, and J. R. Johnson. 2000. Escherichia coli serotype O15:K52:H1 as a uropathogenic clone. J. Clin. Microbiol. 38:201-209.
33. Robicsek, A., G. A. Jacoby, and D. C. Hooper. 2006. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6:629-640.
34. Rock, W., R. Colodner, B. Chazan, M. Elias, and R. Raz. 2007. Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005). Isr. Med. Assoc. J. 9:803-805.
35. Sawai, T., R. Hiruma, N. Kawana, M. Kaneko, F. Taniyasu, and A. Inami. 1982. Outer membrane permeation of β-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae. Antimicrob. Agents Chemother. 22:585-592.
36. Smith, S. P., A. R. Manges, and L. W. Riley. 2008. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition. Clin. Infect. Dis. 46:689-695.
37. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
38. Wang, G., T. S. Whittam, C. M. Berg, and D. E. Berg. 1993. RAPD (arbitrary primer) PCR is more sensitive than multilocus enzyme electrophoresis for distinguishing related bacterial strains. Nucleic Acids Res. 21:5930-5933.
39. Wang, H., J. L. Dzink-Fox, M. Chen, and S. B. Levy. 2001. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob. Agents Chemother. 45: 1515-1521.
40. Xu, X., S. Wu, X. Ye, Y. Liu, W. Shi, Y. Zhang, and M. Wang. 2007. Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1. Antimicrob. Agents Chemother. 51:4105-4110.
41. Zahnel, G. G., T. L. Hisanaga, N. M. Laing, M. R. DeCorby, K. A. Nichol, L. P. Palatnik, J. Johnson, A. Noreddin, G. K. Harding, L. E. Nicolle, D. J. Hoban, and the NAUTICA Group. 2005. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int. J. Antimicrob. Agents 26:380-388.